Nick Walsh

1.5k total citations
42 papers, 950 citations indexed

About

Nick Walsh is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Nick Walsh has authored 42 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 24 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in Nick Walsh's work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Nick Walsh is often cited by papers focused on Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Nick Walsh collaborates with scholars based in Australia, United Kingdom and United States. Nick Walsh's co-authors include Lisa Maher, Philippa Easterbrook, Elie A. Akl, Annette Verster, Michelle Rodolph, Ying‐Ru Lo, Joseph D. Tucker, Mellanye Lackey, Polin Chan and Ji Young Kim and has published in prestigious journals such as Journal of Hepatology, The Lancet Infectious Diseases and Emerging infectious diseases.

In The Last Decade

Nick Walsh

40 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Walsh Australia 17 736 541 262 102 65 42 950
Susan Cowan Denmark 17 421 0.6× 206 0.4× 222 0.8× 63 0.6× 62 1.0× 45 705
Catherine Troisi United States 14 515 0.7× 382 0.7× 382 1.5× 43 0.4× 70 1.1× 31 892
Tullio Prestileo Italy 14 452 0.6× 294 0.5× 387 1.5× 26 0.3× 100 1.5× 32 730
Nadine Kronfli Canada 18 527 0.7× 365 0.7× 345 1.3× 44 0.4× 24 0.4× 78 827
Lars Peters Denmark 21 1.0k 1.4× 993 1.8× 438 1.7× 148 1.5× 115 1.8× 52 1.6k
Michael Levy Australia 11 406 0.6× 330 0.6× 108 0.4× 65 0.6× 29 0.4× 16 546
Anil Suryaprasad United States 10 588 0.8× 365 0.7× 182 0.7× 156 1.5× 10 0.2× 17 719
Stacey Trooskin United States 16 527 0.7× 490 0.9× 217 0.8× 30 0.3× 29 0.4× 30 725
Sheila Cameron United Kingdom 13 580 0.8× 452 0.8× 155 0.6× 100 1.0× 33 0.5× 21 676
Lisette Johnson United States 9 1.2k 1.6× 811 1.5× 664 2.5× 137 1.3× 195 3.0× 9 1.6k

Countries citing papers authored by Nick Walsh

Since Specialization
Citations

This map shows the geographic impact of Nick Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Walsh more than expected).

Fields of papers citing papers by Nick Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Walsh. The network helps show where Nick Walsh may publish in the future.

Co-authorship network of co-authors of Nick Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Walsh. A scholar is included among the top collaborators of Nick Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Walsh. Nick Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nayagam, Shevanthi, Margaret J. de Villiers, Yusuke Shimakawa, et al.. (2023). Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study. ˜The œLancet. Gastroenterology & hepatology. 8(7). 635–645. 15 indexed citations
2.
Wilson, Donald, et al.. (2023). Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021. Emerging infectious diseases. 29(1). 226–228. 2 indexed citations
3.
Walsh, Nick, et al.. (2022). Building a safety culture for infection prevention and control adherence at Howard Springs: A workplace survey. Infection Disease & Health. 28(1). 47–53. 7 indexed citations
4.
Walsh, Nick, et al.. (2022). An outdoor hotel quarantine facility model in Australia: best practice with optimal outcomes. Australian and New Zealand Journal of Public Health. 46(5). 633–639. 5 indexed citations
5.
Zheng, Hui, Nick Walsh, Olufunmilayo Lesi, & Fuqiang Cui. (2022). New progress towards elimination of mother-to-child transmission of hepatitis B virus in China. Hepatology International. 16(6). 1273–1281. 5 indexed citations
6.
Clezy, Kate, et al.. (2022). Electronic monitoring of doffing using video surveillance to minimise error rate and increase safety at Howard Springs International Quarantine Facility. Antimicrobial Resistance and Infection Control. 11(1). 120–120. 2 indexed citations
7.
Easterbrook, Philippa, et al.. (2021). New WHO guidance for country validation of viral hepatitis B and C elimination. ˜The œLancet. Gastroenterology & hepatology. 6(10). 778–780. 37 indexed citations
8.
Llamosas‐Falcón, Laura, Kevin D. Shield, Omer S. M. Hasan, et al.. (2021). Impact of alcohol on the progression of HCV-related liver disease: A systematic review and meta-analysis. Journal of Hepatology. 75(3). 536–546. 16 indexed citations
9.
Benzaken, Adele Schwartz, Gérson Fernando Mendes Pereira, Simone Monzani Vivaldini, et al.. (2019). Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach. The Brazilian Journal of Infectious Diseases. 23(3). 182–190. 34 indexed citations
10.
Li, Xi, Polin Chan, Hui Zhuang, et al.. (2018). Prevalence of hepatitis C virus infection among key populations in China: A systematic review. International Journal of Infectious Diseases. 80. 16–27. 20 indexed citations
11.
Tucker, Joseph D., Kathrine Meyers, John Best, et al.. (2017). The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing. BMC Infectious Diseases. 17(S1). 701–701. 16 indexed citations
12.
Ishizaki, Azumi, Julie Bouscaillou, Niklas Luhmann, et al.. (2017). Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries. BMC Infectious Diseases. 17(S1). 696–696. 45 indexed citations
13.
Zhou, Kali, Thomas Fitzpatrick, Nick Walsh, et al.. (2016). Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses. The Lancet Infectious Diseases. 16(12). 1409–1422. 109 indexed citations
14.
Alavi, Maryam, Tim Spelman, Gail Matthews, et al.. (2015). Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C. International Journal of Drug Policy. 26(10). 976–983. 32 indexed citations
15.
Walsh, Nick, Anne Mijch, Kerrie Watson, et al.. (2014). HIV treatment outcomes among people who inject drugs in Victoria, Australia. BMC Infectious Diseases. 14(1). 707–707. 10 indexed citations
16.
Walsh, Nick & Lisa Maher. (2012). HIV and viral hepatitis C coinfection in people who inject drugs. Current Opinion in HIV and AIDS. 7(4). 339–344. 20 indexed citations
17.
Walsh, Nick, Tania Gibbie, & Peter Higgs. (2008). The development of peer educator‐based harm reduction programmes in northern Vietnam. Drug and Alcohol Review. 27(2). 200–203. 18 indexed citations
18.
Walsh, Nick, et al.. (2008). The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm Reduction Journal. 5(1). 8–8. 74 indexed citations
19.
Dwyer, Robyn, Libby Topp, Lisa Maher, et al.. (2008). Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug and Alcohol Dependence. 100(1-2). 9–16. 75 indexed citations
20.
Walsh, Nick, Megan S. C. Lim, & Margaret Hellard. (2008). Using a surveillance system to identify and treat newly acquired hepatitis C infection. Journal of Gastroenterology and Hepatology. 23(12). 1891–1894. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Cowan Breakdown of academic impact, for papers by Catherine Troisi Breakdown of academic impact, for papers by Tullio Prestileo Breakdown of academic impact, for papers by Nadine Kronfli Breakdown of academic impact, for papers by Lars Peters Breakdown of academic impact, for papers by Michael Levy Breakdown of academic impact, for papers by Anil Suryaprasad Breakdown of academic impact, for papers by Stacey Trooskin Breakdown of academic impact, for papers by Sheila Cameron Breakdown of academic impact, for papers by Lisette Johnson
Rankless by CCL
2026